Showing results (211-220 of 330) with videos related to

Sort By:
Pageof 33
Journal of Affective Disorders|April 18, 1998
The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysisN Mittmann, N Herrmann, T R Einarson, et al.
Journal of the Peripheral Nervous System : JPNS|June 9, 2020
Validation of the Italian version of the Charcot-Marie-Tooth Health IndexChiara Pisciotta, Emma Ciafaloni, Riccardo Zuccarino, et al.
Frontiers in Neurology|July 14, 2022
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1AKaty Eichinger, Janet E Sowden, Joshua Burns, et al.
Acta Psychiatrica Scandinavica|September 19, 2017
Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sampleD M Blumberger, D P Seitz, N Herrmann, et al.
Neurology|August 12, 2024
Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4JReza Sadjadi, Vincent Picher-Martel, Jasper M Morrow, et al.
Biosensors & Bioelectronics|December 20, 2003
Electric chips for rapid detection and quantification of nucleic acidsM Gabig-Ciminska, A Holmgren, H Andresen, et al.
Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth diseaseJoshua Burns, Manoj Menezes, Richard S Finkel, et al.
Muscle & Nerve|March 16, 2018
Somatotopic heat pain thresholds and intraepidermal nerve fibers in healthJenny L Davies, Janean K Engelstad, Linde E Gove, et al.
Neurology|November 1, 2015
Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndromeRoger G Whittaker, David N Herrmann, Boglarka Bansagi, et al.
Pageof 33